IGFBP-3 expression in hepatocellular carcinoma involves abnormalities in TGF-ß and/or Rb signaling pathways

Eiichiro Yumoto, Harushige Nakatsukasa, Tadashi Hanafusa, Yasuhiro Yumoto, Kazuhiro Nouso, Eiji Matsumoto, Toru Onishi, Yoshitaka Takuma, Hironori Tanaka, Tatsuya Fujikawa, Mayumi Suzuki, Masayuki Uemura, Yasushi Shiratori

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Insulin-like growth factor binding protein-3 (IGFBP-3) is a mediator of growth suppression signals and a putative tumor suppressor gene. The growth suppression mechanisms of IGFBP-3 have not been well clarified. We examined the expression of IGFBP-3 transcripts in human hepatocellular carcinoma (HCC) and the relationship between IGFBP-3 expression and the transforming growth factor-6 (TGF-ß) and/or retinoblastoma (Rb) signaling pathways. In situ hybridization revealed IGFBP-3 transcripts in cancer cells in 6 of 57 (10%) HCCs, including moderately and poorly differentiated HCCs with intrahepatic metastasis. In contrast, all lung metastatic nodules of 4 HCCs showed IGFBP-3 transcripts in cancer cells. The cDNA microarray showed that genes for the TGF-ß pathway and Rb were up-regulated in IGFBP-3-expressing HCCs. In 6 HCCs presenting IGFBP-3, immunohistochemical analyses showed abnormalities in the TGF-B and/or Rb pathways; the loss of phosphorylated-Smad2 was observed in 2, and overexpression of phosphorylated-Rb was observed in the remaining 4 HCCs. The present study suggests that IGFBP-3 mediates growth suppression signals via the TGF-B and/or Rb pathways in HCC.

Original languageEnglish
Pages (from-to)1223-1230
Number of pages8
JournalInternational Journal of Oncology
Volume27
Issue number5
Publication statusPublished - Nov 2005

    Fingerprint

Keywords

  • Hepatocellular carcinoma
  • In situ hybridization
  • Insulin-like growth factor binding protein-3
  • Retinoblastoma
  • Transforming growth factor-8

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Yumoto, E., Nakatsukasa, H., Hanafusa, T., Yumoto, Y., Nouso, K., Matsumoto, E., Onishi, T., Takuma, Y., Tanaka, H., Fujikawa, T., Suzuki, M., Uemura, M., & Shiratori, Y. (2005). IGFBP-3 expression in hepatocellular carcinoma involves abnormalities in TGF-ß and/or Rb signaling pathways. International Journal of Oncology, 27(5), 1223-1230.